HRP20190341T1 - Dijagnosticiranje srčane insuficijencije - Google Patents

Dijagnosticiranje srčane insuficijencije Download PDF

Info

Publication number
HRP20190341T1
HRP20190341T1 HRP20190341TT HRP20190341T HRP20190341T1 HR P20190341 T1 HRP20190341 T1 HR P20190341T1 HR P20190341T T HRP20190341T T HR P20190341TT HR P20190341 T HRP20190341 T HR P20190341T HR P20190341 T1 HRP20190341 T1 HR P20190341T1
Authority
HR
Croatia
Prior art keywords
igfbp2
heart failure
concentration
patient
quantification
Prior art date
Application number
HRP20190341TT
Other languages
English (en)
Croatian (hr)
Inventor
Philippe Rouet
Fatima SMIH-ROUET
Franck Desmoulin
Michel Galinier
Original Assignee
Institut National De La Santé Et De La Recherche Médicale (Inserm)
Université Paul Sabatier Toulouse Iii
Centre Hospitalier Universitaire De Toulouse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National De La Santé Et De La Recherche Médicale (Inserm), Université Paul Sabatier Toulouse Iii, Centre Hospitalier Universitaire De Toulouse filed Critical Institut National De La Santé Et De La Recherche Médicale (Inserm)
Publication of HRP20190341T1 publication Critical patent/HRP20190341T1/hr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4745—Insulin-like growth factor binding protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G01N27/44704—Details; Accessories
    • G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
    • G01N27/4473—Arrangements for investigating the separated zones, e.g. localising zones by electric means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • External Artificial Organs (AREA)
  • Paper (AREA)
HRP20190341TT 2012-08-09 2013-08-09 Dijagnosticiranje srčane insuficijencije HRP20190341T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12305988 2012-08-09
PCT/EP2013/066697 WO2014023820A1 (en) 2012-08-09 2013-08-09 Diagnostic of heart failure
EP13747847.5A EP2883057B1 (en) 2012-08-09 2013-08-09 Diagnostic of heart failure

Publications (1)

Publication Number Publication Date
HRP20190341T1 true HRP20190341T1 (hr) 2019-05-31

Family

ID=48953397

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20190341TT HRP20190341T1 (hr) 2012-08-09 2013-08-09 Dijagnosticiranje srčane insuficijencije

Country Status (16)

Country Link
US (2) US20150219669A1 (enExample)
EP (1) EP2883057B1 (enExample)
JP (2) JP6298054B2 (enExample)
CY (1) CY1121406T1 (enExample)
DK (1) DK2883057T3 (enExample)
ES (1) ES2713098T3 (enExample)
HR (1) HRP20190341T1 (enExample)
HU (1) HUE042708T2 (enExample)
LT (1) LT2883057T (enExample)
PL (1) PL2883057T3 (enExample)
PT (1) PT2883057T (enExample)
RS (1) RS58553B1 (enExample)
SI (1) SI2883057T1 (enExample)
SM (1) SMT201900108T1 (enExample)
TR (1) TR201902555T4 (enExample)
WO (1) WO2014023820A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2725906T3 (es) * 2013-06-06 2019-09-30 Inst Nat Sante Rech Med Biomarcador de rehospitalización tras insuficiencia cardíaca
JP7401442B2 (ja) * 2018-01-31 2023-12-19 イントラ-セルラー・セラピーズ・インコーポレイテッド 新規使用
US12699104B2 (en) * 2019-11-06 2026-08-04 National University Corporation Kagawa University Heart failure marker
CN120053474B (zh) * 2025-02-26 2025-12-12 浙江大学 辅酶a在制备心肌细胞铁死亡抑制剂中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060183681A1 (en) * 2005-02-14 2006-08-17 Bio-Rad Laboratories, Inc. Stabilized compositions containing natriuretic peptides
JP4465469B2 (ja) * 2005-02-21 2010-05-19 国立大学法人佐賀大学 循環器病マーカーとしてのインターロイキン13
EP1722232A1 (en) * 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Devices and methods for diagnosing or predicting early stage cardiac dysfunctions
US20080166734A1 (en) * 2005-12-21 2008-07-10 David Xing-Fei Deng Genes and methods of using the same for diagnosis and for targeting the therapy of cardiovascular disease
WO2008005469A2 (en) 2006-06-30 2008-01-10 Schering Corporation Igfbp2 biomarker
DK2115477T3 (en) 2007-01-25 2015-08-10 Hoffmann La Roche USE OF IGFBP-7 IN THE EVIDENCE OF HEART FAILURE
EP2310860A1 (en) * 2008-07-30 2011-04-20 INSERM - Institut National de la Santé et de la Recherche Médicale Blood glutathione as a biomarker for screening asymptomatic patients at risk for heart failure
PT2829881T (pt) * 2010-07-14 2017-11-29 Commw Scient Ind Res Org Diagnóstico para cancro colo-rectal
ES2627337T3 (es) * 2010-08-26 2017-07-27 F. Hoffmann-La Roche Ag Uso de biomarcadores para controlar una medicación en un sujeto que padece insuficiencia cardíaca
EP2841945A4 (en) 2012-04-24 2016-04-27 Astute Medical Inc METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING OF STROKE OR OTHER BRAINS
US20140206632A1 (en) * 2013-01-22 2014-07-24 Singulex, Inc. Endothelin in the Diagnosis of Cardiac Disease

Also Published As

Publication number Publication date
CY1121406T1 (el) 2020-05-29
JP2018109640A (ja) 2018-07-12
PT2883057T (pt) 2019-03-06
TR201902555T4 (tr) 2019-03-21
ES2713098T3 (es) 2019-05-17
LT2883057T (lt) 2019-04-25
SMT201900108T1 (it) 2019-05-10
WO2014023820A1 (en) 2014-02-13
DK2883057T3 (en) 2019-03-18
SI2883057T1 (sl) 2019-07-31
EP2883057B1 (en) 2018-12-05
JP2015528562A (ja) 2015-09-28
US11061037B2 (en) 2021-07-13
JP6298054B2 (ja) 2018-03-20
HUE042708T2 (hu) 2019-07-29
US20180143208A1 (en) 2018-05-24
JP6595641B2 (ja) 2019-10-23
RS58553B1 (sr) 2019-05-31
US20150219669A1 (en) 2015-08-06
PL2883057T3 (pl) 2019-07-31
EP2883057A1 (en) 2015-06-17

Similar Documents

Publication Publication Date Title
Jadon et al. Recent trends in electrochemical sensors for multianalyte detection–A review
Vashist et al. Bioanalytical advances in assays for C-reactive protein
You et al. Tear fluid protein biomarkers
JP2013533977A5 (enExample)
WO2010046443A3 (en) Methods for detection and diagnosis of a bone or cartilage disorder
BR112014016313A2 (pt) medições precisas de analito para tira de teste eletroquímico com base em característica(s) física(s) detectada(s) da amostra contendo o analito e parâmetros de biossensores derivados
WO2015006489A8 (en) Blood-based screen for detecting neurological diseases in primary care settings
RU2013138721A (ru) Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови
JP2013511735A5 (enExample)
HK1249182A1 (zh) 验证生物标志物测量
BR112015008473A2 (pt) aparelho e método para determinar a quantidade de uma proteína alvo e/ou outros tipos de biomarcadores ou analitos presentes em uma amostra
WO2009152269A3 (en) Methods of quantifying biomarkers
WO2015031676A3 (en) Integrity testing of hair samples
JP2019531261A5 (enExample)
DE602005001299D1 (de) Kombinationen von Markern zum Nachweis von typ 1 und 2 Diabetes
JP2018004657A5 (enExample)
JP2012521551A5 (enExample)
JP2015528562A5 (enExample)
IN2014DN08430A (enExample)
WO2013121368A3 (en) A process for detection and optional quantification of an analyte
HRP20190801T1 (hr) Biološki biljeg za rehospitalizaciju nakon srčane insuficijencije
JP2017524933A5 (enExample)
EA201400571A1 (ru) Специфичные к трансресвератролу антитела и их применение
ATE546731T1 (de) Schnelles homogenes immunoassay unter verwendung von elektrophorese
WO2016100117A3 (en) Accurate assay measurement of hydrophobic haptenic analytes